Your browser doesn't support javascript.
loading
Increasing compliance with a clinical practice guideline for fetal fibronectin testing and the management of threatened preterm labour: A quality improvement project.
Dawes, Lisa K; Subramoney, Malini; Miller, Laura M; Groom, Katie M.
Afiliação
  • Dawes LK; National Women's Health, Auckland City Hospital, New Zealand; Department of Obstetrics & Gynaecology, University of Auckland, New Zealand. Electronic address: ldawes@adhb.govt.nz.
  • Subramoney M; Performance Improvement Team, Auckland City Hospital, New Zealand.
  • Miller LM; National Women's Health, Auckland City Hospital, New Zealand.
  • Groom KM; National Women's Health, Auckland City Hospital, New Zealand; Department of Obstetrics & Gynaecology, University of Auckland, New Zealand.
Eur J Obstet Gynecol Reprod Biol ; 221: 89-96, 2018 Feb.
Article em En | MEDLINE | ID: mdl-29275278
OBJECTIVE: To increase adherence to a local hospital clinical practice guideline for the use of fetal fibronectin testing in women presenting with symptoms of threatened preterm labour. STUDY DESIGN: A quality improvement project using a multi-faceted implementation strategy. SETTING: National Women's Health, Auckland City Hospital; a tertiary referral maternity unit in Auckland, New Zealand. POPULATION: All obstetricians, junior obstetric doctors and hospital employed midwives. METHODS: A pre-education audit and survey, compulsory interactive educational intervention with audit feedback and provision of reminders followed by a post-education audit and survey one year later. MAIN OUTCOME MEASURES: Number of fetal fibronectin tests performed, proportion of tests performed meeting clinical criteria for testing and proportion of results managed according to hospital guideline. RESULTS: There was a 25% increase in the number of tests performed with an increase in the proportion that met clinical criteria for testing, 76% (31/41)-93% (51/55) (OR 4.1, 95% CI 1.2-14.2). Adherence to guidelines for clinical management according to fFN results changed over time, 80% (33/41)-95% (52/55) (OR 4.2, 95% CI 1.04-17.0). Clinician knowledge on some (but not all) indications for fFN testing improved. Education and reminders did not improve understanding of clinical scenarios that may result in a false positive fFN test. CONCLUSIONS: A multi-faceted approach of audit and clinician feedback, interactive education and reminders supports the implementation of a clinical practice guideline for the use of fFN as a preterm birth prediction test for women presenting with symptoms of threatened preterm labour.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibronectinas / Guias de Prática Clínica como Assunto / Fidelidade a Diretrizes / Melhoria de Qualidade / Trabalho de Parto Prematuro Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research Limite: Female / Humans / Pregnancy Idioma: En Revista: Eur J Obstet Gynecol Reprod Biol Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibronectinas / Guias de Prática Clínica como Assunto / Fidelidade a Diretrizes / Melhoria de Qualidade / Trabalho de Parto Prematuro Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research Limite: Female / Humans / Pregnancy Idioma: En Revista: Eur J Obstet Gynecol Reprod Biol Ano de publicação: 2018 Tipo de documento: Article